(Q77959574)

English

Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery

scientific article published on 01 December 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

G Melnik

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

W H Schwesinger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

L C Dogolo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Teng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Vincent

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

The American Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

176

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

6A Suppl

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

14S-17S

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

In vitro activity of the new fluoroquinolone CP-99,219.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against gram-positive cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

Surgical infections: prevention and treatment--1965 to 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

The chemistry and biological profile of trovafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900214-1

7 January 2021

Identifiers

10.1016/S0002-9610(98)00214-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935251%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77959574&oldid=1946519267"